Biotechnology company
Appears in 1 story
Developer of Certitude, scaling nationwide
For women with dense breast tissue, a mammogram detects only about half of cancers. On September 29, Astrin Biosciences said its Certitude blood test, which flags early-stage breast cancer from a simple blood draw, is now available to 75 million women through telehealth infrastructure company OpenLoop Health.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
